- Condition: Ankylosing Spondyloarthritis
Interventions: Drug: Apremilast tablet 20 mg; Drug: Apremilast tablet 30 mg BID; Drug: Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified May 2012 - Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation; Procedure: External Fixation; Procedure: Percutaneous Pinning; Procedure: Closed Reduction and casting
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott; CATO Research Canada; JSS Medical Research Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Osteoarthritis of the Shoulder
Interventions: Device: Zimmer TM Glenoid; Device: Cemented Glenoid
Sponsors: Joint Preservation Centre of BC; Joint Preservation Centre of BC
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified February 2012 - Condition: Tophaceous Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified March 2012 - Condition: Gout
Interventions: Drug: lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Conditions: Knee Joint Arthritis; Knee Joint Arthroplasty
Interventions: Procedure: Spinal anesthesia with periarticular infiltration; Procedure: Femoral and sciatic nerve blocks; Procedure: Periarticular infusions
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified January 2012 - Condition: Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Adalimumab
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: FX006; Drug: Commercially available triamcinolone acetonide
Sponsors: Flexion Therapeutics, Inc.; Flexion Therapeutics, Inc.
Not yet recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3-and 4-part Proximal Humeral Fractures; Avascular Necrosis; Gross Rotator Cuff Deficiency; Failed Total Shoulder Arthroplasty (Both Glenoid and Humeral Components Require Revision
Intervention: Device: Trabecular Metal Reverse Shoulder System
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3- and 4-part Proximal Humeral Fractures; Avascular Necrosis
Intervention: Device: Trabecular Metal Humeral Stem
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified April 2012 - Condition: Arthritis, Psoriatic
Interventions: Biological: Placebo matching BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified January 2012 - Conditions: Systemic Sclerosis; Ulcers
Interventions: Drug: macitentan 3mg; Drug: macitentan 10mg; Drug: placebo
Sponsors: Actelion; Actelion
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis, Arthritis, Juvenile Rheumatoid
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Conditions: Osteoarthritis Knee; Postoperative Pain
Interventions: Device: echogenic needle and catheter; Device: Neurostimulation to position needle and catheter
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Physicians' Services Incorporated Foundation
Not yet recruiting - verified January 2012 - Condition: Acute Gouty Arthritis
Intervention: Drug: Canakinumab 150mg in prefilled syringe
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Psoriatic Arthritis
Interventions: Drug: AMG 827; Drug: Placebo; Drug: AMG 827
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Chronic Gouty Arthritis
Intervention: Biological: canakinumab
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Lumbar Spine Degeneration
Interventions: Device: INFUSE Bone Graft; Other: Iliac Crest Bone Graft
Sponsors: Medtronic Spinal and Biologics; Medtronic Spinal and Biologics
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: ISIS CRP Rx or Placebo
Sponsors: Isis Pharmaceuticals; Isis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo Comparator
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: Abbott; Abbott; JSS Medical Research Inc.; CATO Research Canada
Recruiting - verified April 2012 - Condition: Psoriasis
Intervention:
Sponsors: Abbott; Abbott; CATO Research Canada; JSS Medical Research Inc.
Recruiting - verified May 2012 - Condition: Gout
Intervention: Drug: Allopurinol
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Secukinumab (75 mg); Drug: Secukinumab (150 mg); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: BMS-945429 Placebo; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Drug: Methotrexate; Drug: Methotrexate; Drug: Methotrexate Placebo; Drug: Methotrexate; Drug: Adalimumab Placebo; Drug: Adalimumab
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: prednisone; Other: prednisone; Other: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: Observational study
Sponsors: Canadian Research & Education in Arthritis; Canadian Research & Education in Arthritis; Abbott
Recruiting - verified November 2011 - Condition: Osteoarthritis of the Knee
Interventions: Other: Commercially spearmint tea; Other: High Rosmarinic Acid Spearmint Tea
Sponsors: University of Guelph; University of Guelph; Ontario Ministry of Agriculture and Rural Affairs
Recruiting - verified April 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: secukinumab; Biological: secukinumab; Biological: placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Acute Gouty Arthritis
Interventions: Drug: Canakinumab pre-filled syringe; Drug: Canakinumab lyophilized cake; Drug: Triamcinolone Acetonide
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Hammond, Allan, M.D.; Hammond, Allan, M.D.
Recruiting - verified June 2011 - Condition: Knee Osteoarthritis
Intervention: Drug: Chondroitin sulfate
Sponsors: Bioiberica; Bioiberica
Recruiting - verified August 2011 - Condition: Early Inflammatory Arthritis
Interventions: Behavioral: One-on-one peer support; Behavioral: Standard of care
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; Mount Sinai Hospital, Toronto, Canada; The Arthritis Society, Canada; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Condition: Early Inflammatory Arthritis
Intervention: Behavioral: Peer Mentor Training
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; The Arthritis Society, Canada; Mount Sinai Hospital, Toronto, Canada; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Condition: Osteoarthritis, Hip
Intervention:
Sponsors: McMaster University; McMaster University; DePuy Orthopaedics
Not yet recruiting - verified July 2011 - Condition: Cardiovascular Disease, Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: etanercept
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: etanercept
Sponsors: Amgen; Amgen
Recruiting - verified March 2012 - Conditions: Degenerative Joint Disease; Congenital Deformity; Arthritis; Osteoarthritis; Rheumatoid Arthritis
Interventions: Device: Augment(tm) Injectable Bone Graft; Procedure: Autologous bone graft
Sponsors: BioMimetic Therapeutics; BioMimetic Therapeutics
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: TcLand Expression S.A.; TcLand Expression S.A.; Premier Research Group plc; Theradis pharma; Medpharmgene Inc.
Recruiting - verified October 2011 - Condition: Arthritis
Intervention: Device: Placement of different catheters for continuous nerve block
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre
Recruiting - verified March 2012 - Condition: Fibromyalgia
Interventions: Drug: pregabalin; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Device: ADM Cup
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Adalimumab and placebo of fostamatinib; Drug: Placebo of fostamatinib, fostamatinib, and placebo injections
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Conditions: Idiopathic Bronchiectasis; Nontuberculous Mycobacterium (NTM) Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast; Drug: • Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified June 2011 - Condition: Osteoarthritis
Interventions: Procedure: OtisMed; Procedure: Computer Assisted Surgery (CAS)
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified January 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: CNTO 148 (Golimumab); Biological: CNTO 148 (golimumab) or placebo
Sponsors: Centocor, Inc.; Centocor, Inc.; Schering-Plough (Ireland) Company
Recruiting - verified May 2012 - Conditions: Churg-Strauss Syndrome; Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener's); Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu's Arteritis
Intervention:
Sponsors: Boston University; Boston University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Rare Diseases (ORD); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: Part 1: Etoricoxib 60 mg; Drug: Part 1: Etoricoxib 90 mg; Drug: Part 2: Etoricoxib 60 mg; Drug: Part 2: Etoricoxib 90 mg; Drug: Part 1: Placebo to Etoricoxib 60 mg; Drug: Part 1: Placebo to Etoricoxib 90 mg; Drug: Part 2: Placebo to Etoricoxib 60 mg; Drug: Part 2: Placebo to Etoricoxib 90 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: fostamatinib; Drug: fostamatinib; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Part I - etoricoxib 60 mg; Drug: Part I - etoricoxib 90 mg; Drug: Part I- naproxen 1000 mg; Drug: Part I - Placebo to etoricoxib 60 mg; Drug: Part I - Placebo to etoricoxib 90 mg; Drug: Part I - Placebo to naproxen 500 mg; Drug: Part II- etoricoxib 60 mg; Drug: Part II- etoricoxib 90 mg; Drug: Part II- naproxen 1000 mg; Drug: Part II - Placebo to etoricoxib 60 mg; Drug: Part II - Placebo to etoricoxib 90 mg; Drug: Part II - Placebo to naproxen 500 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Early Rheumatoid Arthritis
Interventions: Biological: adalimumab; Drug: methotrexate
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Condition: Acute Gout
Intervention: Drug: ACZ885
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Osteoarthritis
Intervention: Device: Trabecular Metal Modular Tibial Total Knee Component
Sponsors: Dalhousie University; Dalhousie University; Zimmer, Inc.
Recruiting - verified January 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.; Jason Jones, MS, Group Director, Clinical Affairs, Smith&Nephew
Recruiting - verified August 2011 - Conditions: Psoriatic Arthritis; Psoriasis
Intervention:
Sponsors: Innovaderm Research Inc.; Innovaderm Research Inc.; Amgen
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept; Drug: Methotrexate; Drug: Abatacept Placebo; Drug: Methotrexate Placebo
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab; Drug: Methotrexate
Sponsors: Abbott; Abbott; Mount Sinai Hospital, Canada
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott; University Health Network, Toronto
Recruiting - verified May 2012 - Condition: Lupus Arthritis
Interventions: Drug: Laquinimod; Drug: Laquinimod; Other: Placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Recruiting - verified May 2012 - Condition: Arthritis, Psoriatic
Interventions: Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: ustekinumab
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Condition: Knee Osteoarthritis
Interventions: Dietary Supplement: Glucosamine sulphate; Other: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: SAR153191 (REGN88); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified May 2012 - Condition: Osteoarthritis, Hip
Intervention:
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.
Recruiting - verified July 2011 - Condition: Active Rheumatoid Arthritis
Intervention: Drug: SBI-087
Sponsors: Pfizer; Pfizer; Emergent Product Development Seattle LLC
Recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Device: Cormet; Device: Conserve
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Corin
Recruiting - verified December 2011 - Conditions: Chronic Allograft Nephropathy; Chronic Kidney Disease; Chronic Renal Failure; Disordered Mineral Metabolism; End Stage Renal Disease; Hyperparathyroidism; Hypophosphatemia; Kidney Disease; Kidney Transplantation; Post Renal Transplantation
Interventions: Drug: Cinacalcet; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: First MTP Joint Osteoarthritis
Interventions: Device: Arthrodesis; Device: Cartiva
Sponsors: Carticept Medical, Inc; Carticept Medical, Inc
Recruiting - verified August 2011 - Condition: Arthropathy of Knee Joint
Interventions: Procedure: Total Knee Arthroplasty; Procedure: Motion analysis
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Wright Medical Technology
Not yet recruiting - verified December 2011 - Conditions: Hip Joint; Osteoarthritis; Arthroplasty
Interventions: Device: A Class BFH; Device: Metal on Polyethylene
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Wright Medical Technology
Recruiting - verified October 2011 - Conditions: Osteoarthritis; Traumatic Arthritis; Avascular Necrosis of the Femoral Condyle; Moderate Varus; Valgus; Flexion Deformities
Intervention: Device: NexGen LPS-Flex Mobile Bearing Knee
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified April 2012 - Condition: Scoliosis
Interventions: Procedure: Surgical intervention; Other: Non operative intervention
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Northwestern University; New York University; University of Virginia; University of Louisville; Maryland Spine Center; Hospital for Special Surgery, New York; University Health Network, Toronto; Hopital du Sacre', Montreal University; Dartmouth-Hitchcock Medical Center
Recruiting - verified April 2012 - Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Condition: Takayasu Arteritis
Intervention:
Sponsors: Boston University; Peter A. Merkel; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Conditions: Crohn Disease; Arthritis, Rheumatoid
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Condition: Osteoarthritis, Carpometacarpal
Interventions: Device: Comfort Cool thumb splint by North Coast Medical; Device: Custom made thermoplastic & neoprene splint
Sponsors: University of British Columbia; University of British Columbia; Vancouver Foundation
Recruiting - verified April 2012 - Condition: Joint Disease
Interventions: Procedure: LRTI; Procedure: Ascension PyroDisk
Sponsors: Simon Fraser Orthopaedic Fund; Simon Fraser Orthopaedic Fund
Recruiting - verified June 2011 - Condition: Hip Arthritis
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified October 2011 - Conditions: Osteoarthritis; Arthroplasty; Hip Replacement
Interventions: Procedure: Motion analysis; Procedure: Motion analysis; Procedure: Motion analysis
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Ankle Arthritis
Interventions: Procedure: Ankle Arthroplasty; Procedure: Ankle Arthrodesis
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Orthopaedic Foot and Ankle Society; Johnson & Johnson
Recruiting - verified May 2009 - Conditions: Hip Fractures; Femoral Neck Fractures
Interventions: Device: Total hip arthroplasty; Device: Hemi-arthroplasty
Sponsors: Boston University; Boston University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Hamilton Health Sciences Corporation; ZonMw: The Netherlands Organisation for Health Research and Development; Canadian Institutes of Health Research (CIHR)
Recruiting - verified October 2011 - Conditions: Psoriasis; Arthritis, Psoriatic
Interventions: Biological: ustekinumab; Biological: Biological therapies other than infliximab and ustekinumab; Drug: conventional systemic agents; Biological: infliximab
Sponsors: Centocor Ortho Biotech Services, L.L.C.; Centocor Ortho Biotech Services, L.L.C.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Intervention: Procedure: Pharmacist-Initiated Intervention in OsteoArthritis (PhIT-OA)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Canadian Arthritis Network; Michael Smith Foundation for Health Research
Not yet recruiting - verified November 2011 - Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; Pfizer; The Cleveland Clinic
Recruiting - verified May 2012 - Condition: Takayasu's Arteritis
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Wegener's
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Temporal Arteritis
Intervention:
Sponsors: Boston University; Peter A. Merkel; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Polyarteritis Nodosa
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Churg-Strauss Syndrome
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Conditions: Rotator Cuff Tear; Osteoarthritis; Shoulder Instability
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified April 2012 - Conditions: Systemic Lupus Erythematosus; Antiphospholipid Syndrome
Intervention:
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified December 2011
 |
Join Clinical Trials in Kenai Peninsula,Alaska |
